Anti-placenta-chondroitin-sulfate chimeric antigen receptor and application thereof
AssigneeGuangzhou Cas Lamvac Biotech Co., Ltd.
InventorsYongchao Yao, Hemei Qi, Wenzhong Guo, Li Qin, Xiaoping Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeGuangzhou Cas Lamvac Biotech Co., Ltd.
InventorsYongchao Yao, Hemei Qi, Wenzhong Guo, Li Qin, Xiaoping Chen
Estimating the term…
The present invention provides an anti-placenta chondroitin sulfate (pl-CS) chimeric antigen receptor and application thereof. The chimeric antigen receptor mainly comprises anti-pl-CS antigen recognition region, a hinge region, a transmembrane region and intracellular region, wherein the anti-pl-CS antigen recognition region is any one of a plasmodium protein VAR2CSA, a part of peptide segment of plasmodium protein VAR2CSA or a pl-CS antibody; and the part of peptide segment of the plasmodium protein VAR2CSA is a peptide segment with the number of amino acid greater than 500 in the plasmodium protein VAR2CSA.
A chimeric antigen receptor of anti-placental-like chondroitin sulfate, mainly comprising an antigen recognition region of anti-pl-CS, a hinge region, a transmembrane region, and an intracellular region in tandem arrangement;
Dependencies are inferred from the claim text.